Hudson River Biotechnology raises new financing for novel breeding techniques
Summary
This can create improvements in yield, higher nutrition composition, or longer shelf life. The European Parliament recently agreed to relax the rules for new genetic techniques such as CRISPR which is a major milestone for global acceptance. A clear distinction is made between, on the one hand, the long-standing GMO crops, which contain transgenic DNA (for example to combine with herbicides) that are still banned from the market, and on the other hand the new CRISPR crops which do not contain transgenic DNA.The fact that Europe is giving the green light is an important step for us, explains Ferdinand Los, CEO and co-founder of Hudson River Biotechnology. Hudson River Biotechnology is a scale-up that has been working on important innovations in plant improvements for years. With this investment, the company can develop further and thus contribute to long-term food security.Hudson River Biotechnology currently employs 30 people.